References
- Lindsay MP, Norrving B, Sacco RL, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2019. London, England: SAGE Publications Sage UK; 2019.
- Malik R, Traylor M, Pulit SL, et al. Low-frequency and common genetic variation in ischemic stroke: the METASTROKE collaboration. Neurology. 2016;86(13):1217–1226. doi:10.1212/WNL.0000000000002528
- Chen CY, Huang YB, Tzu-Chi Lee C. Epidemiology and disease burden of ischemic stroke in Taiwan. Int J Neurosci. 2013;123(10):724–731. doi:10.3109/00207454.2013.796552
- Feigin VL, Nichols E, Alam T, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–480. doi:10.1016/S1474-4422(18)30499-X
- Lin LY, Lee CH, Yu CC, et al. Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation—a nation wide database analysis. Atherosclerosis. 2011;217(1):292–295. doi:10.1016/j.atherosclerosis.2011.03.033
- Hägg S, Thorn LM, Forsblom CM, et al. Different risk factor profiles for ischemic and hemorrhagic stroke in type 1 diabetes mellitus. Stroke. 2014;45(9):2558–2562. doi:10.1161/STROKEAHA.114.005724
- Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120–129. doi:10.1056/NEJMoa1105575
- Kamel H, Okin PM, Elkind MS, Iadecola C. Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke. 2016;47(3):895–900. doi:10.1161/STROKEAHA.115.012004
- Kaithoju S. Ischemic stroke: risk stratification, warfarin teatment and outcome measure. J Atr Fibrillation. 2015;8(4). doi:10.4022/jafib.1144
- Deedwania PC. New oral anticoagulants in elderly patients with atrial fibrillation. Am J Med. 2013;126(4):289–296. doi:10.1016/j.amjmed.2012.10.012
- Yang J, Chen Y, Li X, et al. Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and meta-analysis. Int J Cardiol. 2013;168(4):4234–4243. doi:10.1016/j.ijcard.2013.07.151
- Wadelius M, Chen LY, Eriksson N, et al. Association of warfarin dose with genes involved in its action and metabolism. Hum Genet. 2007;121(1):23–34. doi:10.1007/s00439-006-0260-8
- Claudio-Campos K, Labastida A, Ramos A, et al. Warfarin anticoagulation therapy in Caribbean Hispanics of Puerto Rico: a candidate gene association study. Front Pharmacol. 2017;8:347. doi:10.3389/fphar.2017.00347
- Liu YT, Nfor ON, Wang L, et al. Interaction between sex and LDLR rs688 polymorphism on hyperlipidemia among Taiwan Biobank adult participants. Biomolecules. 2020;10(2):244. doi:10.3390/biom10020244
- Buniello A, MacArthur JA, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005–D1012. doi:10.1093/nar/gky1120
- Ahmed S, Mumtaz MN, Zulfiqar Z, et al. Genetic variations in drug-metabolizing enzyme CYP2C9 among major ethnic groups of Pakistani population. Gene. 2020;746:144659.
- Lubitz SA, Parsons OE, Anderson CD, et al. Atrial fibrillation genetic risk and ischemic stroke mechanisms. Stroke. 2017;48(6):1451–1456. doi:10.1161/STROKEAHA.116.016198
- Tada H, Shiffman D, Smith JG, et al. Twelve–single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke. Stroke. 2014;45(10):2856–2862. doi:10.1161/STROKEAHA.114.006072
- Chen R, Ovbiagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci. 2016;351(4):380–386. doi:10.1016/j.amjms.2016.01.011
- Gorgui J, Gorshkov M, Khan N, Daskalopoulou SS. Hypertension as a risk factor for ischemic stroke in women. Can J Cardiol. 2014;30(7):774–782. doi:10.1016/j.cjca.2014.01.007
- Djelilovic-Vranic J, Tiric-Campara M, Subašić N, Alajbegovic A, Todorović L. Hyperlipidemia-risk factor for development of ischemic stroke: P2254. Eur J Neurol. 2010;17.
- Lindgren A. Stroke genetics: a review and update. J Stroke. 2014;16(3):114. doi:10.5853/jos.2014.16.3.114
- Hsieh MS, Yu SC, Chung WT, et al. Phosphodiesterase 4d (PDE4D) gene variants and risk of ischemic stroke in the Taiwanese population. Lab Med. 2009;40(2):87–90. doi:10.1309/LM4X5PCRN4AECXBB
- Hsieh YC, Seshadri S, Chung WT, et al. Association between genetic variant on chromosome 12p13 and stroke survival and recurrence: a one year prospective study in Taiwan. J Biomed Sci. 2012;19(1):1. doi:10.1186/1423-0127-19-1